Correlation Between Entero Therapeutics, and CapitaLand Investment

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Entero Therapeutics, and CapitaLand Investment at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Entero Therapeutics, and CapitaLand Investment into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Entero Therapeutics, and CapitaLand Investment Limited, you can compare the effects of market volatilities on Entero Therapeutics, and CapitaLand Investment and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Entero Therapeutics, with a short position of CapitaLand Investment. Check out your portfolio center. Please also check ongoing floating volatility patterns of Entero Therapeutics, and CapitaLand Investment.

Diversification Opportunities for Entero Therapeutics, and CapitaLand Investment

-0.14
  Correlation Coefficient

Good diversification

The 3 months correlation between Entero and CapitaLand is -0.14. Overlapping area represents the amount of risk that can be diversified away by holding Entero Therapeutics, and CapitaLand Investment Limited in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on CapitaLand Investment and Entero Therapeutics, is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Entero Therapeutics, are associated (or correlated) with CapitaLand Investment. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of CapitaLand Investment has no effect on the direction of Entero Therapeutics, i.e., Entero Therapeutics, and CapitaLand Investment go up and down completely randomly.

Pair Corralation between Entero Therapeutics, and CapitaLand Investment

Given the investment horizon of 90 days Entero Therapeutics, is expected to under-perform the CapitaLand Investment. In addition to that, Entero Therapeutics, is 3.48 times more volatile than CapitaLand Investment Limited. It trades about -0.21 of its total potential returns per unit of risk. CapitaLand Investment Limited is currently generating about -0.21 per unit of volatility. If you would invest  200.00  in CapitaLand Investment Limited on August 24, 2024 and sell it today you would lose (18.00) from holding CapitaLand Investment Limited or give up 9.0% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy95.65%
ValuesDaily Returns

Entero Therapeutics,  vs.  CapitaLand Investment Limited

 Performance 
       Timeline  
Entero Therapeutics, 

Risk-Adjusted Performance

3 of 100

 
Weak
 
Strong
Insignificant
Compared to the overall equity markets, risk-adjusted returns on investments in Entero Therapeutics, are ranked lower than 3 (%) of all global equities and portfolios over the last 90 days. In spite of very fragile basic indicators, Entero Therapeutics, displayed solid returns over the last few months and may actually be approaching a breakup point.
CapitaLand Investment 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days CapitaLand Investment Limited has generated negative risk-adjusted returns adding no value to investors with long positions. Despite nearly stable essential indicators, CapitaLand Investment is not utilizing all of its potentials. The newest stock price disturbance, may contribute to mid-run losses for the stockholders.

Entero Therapeutics, and CapitaLand Investment Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Entero Therapeutics, and CapitaLand Investment

The main advantage of trading using opposite Entero Therapeutics, and CapitaLand Investment positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Entero Therapeutics, position performs unexpectedly, CapitaLand Investment can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in CapitaLand Investment will offset losses from the drop in CapitaLand Investment's long position.
The idea behind Entero Therapeutics, and CapitaLand Investment Limited pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Global Markets Map module to get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes.

Other Complementary Tools

CEOs Directory
Screen CEOs from public companies around the world
Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon
ETF Categories
List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
AI Portfolio Architect
Use AI to generate optimal portfolios and find profitable investment opportunities